Summary
Glucagon like peptide-1 (GLP-1) agonists is the agonists of the GLP-1 receptor. This class of drugs is used for the treatment of type 2 diabetes. One of their advantages is over older insulin secretagogues, such as sulfonylureas or meglitinides, and they have a lower risk of causing hypoglycemia.
Market Segment as follows:
By Type
Exenatied
Liraglutide
Lixisenatide
Albiglutide
Dulaglutide
By Application
Hospital
Pharmacy
Others
By Company
Novo Nordisk
AstraZeneca
Eli Lily
GSK
Sanofi
Bristol-Myers Squibb
Amylin
The main contents of the report including:
Section 1:
Product definition, type and application, global and China market overview;
Section 2:
Global and China Market competition by company;
Section 3:
Global and China sales revenue, volume and price by type;
Section 4:
Global and China sales revenue, volume and price by application;
Section 5:
China export and import;
Section 6:
Company information, business overview, sales data and product specifications;
Section 7:
Industry chain and raw materials;
Section 8:
SWOT and Porter's Five Forces;
Section 9:
Conclusion.
Interested in this report?
Get your sample now!
Table of Content
1 Market Overview
1.1 Market Segment Overview
1.1.1 Product Definition
1.1.2 Market by Type
1.1.2.1 Exenatied
1.1.2.2 Liraglutide
1.1.2.3 Lixisenatide
1.1.2.4 Albiglutide
1.1.2.5 Dulaglutide
1.1.3 Market by Application
1.1.3.1 Hospital
1.1.3.2 Pharmacy
1.1.3.3 Others
1.2 Global and China Market Size
1.2.1 Global Overview
1.2.2 China Overview
2 Global and China Market by Company
2.1 Global
2.1.1 Global Sales by Company
2.1.2 Global Price by Company
2.2 China
2.2.1 China Sales by Company
2.2.2 China Price by Company
3 Global and China Market by Type
3.1 Global
3.1.1 Global Sales by Type
3.1.2 Global Price by Type
3.2 China
3.2.1 China Sales by Type
3.2.2 China Price by Type
4 Global and China Market by Application
4.1 Global
4.1.1 Global Sales by Application
4.1.2 Global Price by Application
4.2 China
4.2.1 China Sales by Application
4.2.2 China Price by Application
5 China Trade
5.1 Export
5.2 Import
6 Key Manufacturers
6.1 Novo Nordisk
6.1.1 Company Information
6.1.2 Product Specifications
6.1.3 Business Data (Capacity, Sales Revenue, Volume, Price, Cost and Margin)
6.2 AstraZeneca
6.3 Eli Lily
6.4 GSK
6.5 Sanofi
6.6 Bristol-Myers Squibb
6.7 Amylin
7 Industry Upstream
7.1 Industry Chain
7.2 Raw Materials
8 Market Environment
8.1 SWOT
8.2 Porter's Five Forces
9 Conclusion
Figure Exenatied Market Size and CAGR 2013-2018 (Million USD)
Figure Exenatied Market Size and CAGR 2013-2018 (Volume)
Figure Exenatied Market Forecast and CAGR 2019-2025 (Million USD)
Figure Exenatied Market Forecast and CAGR 2019-2025 (Volume)
Figure Liraglutide Market Size and CAGR 2013-2018 (Million USD)
Figure Liraglutide Market Size and CAGR 2013-2018 (Volume)
Figure Liraglutide Market Forecast and CAGR 2019-2025 (Million USD)
Figure Liraglutide Market Forecast and CAGR 2019-2025 (Volume)
Figure Lixisenatide Market Size and CAGR 2013-2018 (Million USD)
Figure Lixisenatide Market Size and CAGR 2013-2018 (Volume)
Figure Lixisenatide Market Forecast and CAGR 2019-2025 (Million USD)
Figure Lixisenatide Market Forecast and CAGR 2019-2025 (Volume)
Figure Albiglutide Market Size and CAGR 2013-2018 (Million USD)
Figure Albiglutide Market Size and CAGR 2013-2018 (Volume)
Figure Albiglutide Market Forecast and CAGR 2019-2025 (Million USD)
Figure Albiglutide Market Forecast and CAGR 2019-2025 (Volume)
Figure Dulaglutide Market Size and CAGR 2013-2018 (Million USD)
Figure Dulaglutide Market Size and CAGR 2013-2018 (Volume)
Figure Dulaglutide Market Forecast and CAGR 2019-2025 (Million USD)
Figure Dulaglutide Market Forecast and CAGR 2019-2025 (Volume)
Figure Hospital Market Size and CAGR 2013-2018 (Million USD)
Figure Hospital Market Size and CAGR 2013-2018 (Volume)
Figure Hospital Market Forecast and CAGR 2019-2025 (Million USD)
Figure Hospital Market Forecast and CAGR 2019-2025 (Volume)
Figure Pharmacy Market Size and CAGR 2013-2018 (Million USD)
Figure Pharmacy Market Size and CAGR 2013-2018 (Volume)
Figure Pharmacy Market Forecast and CAGR 2019-2025 (Million USD)
Figure Pharmacy Market Forecast and CAGR 2019-2025 (Volume)
Figure Others Market Size and CAGR 2013-2018 (Million USD)
Figure Others Market Size and CAGR 2013-2018 (Volume)
Figure Others Market Forecast and CAGR 2019-2025 (Million USD)
Figure Others Market Forecast and CAGR 2019-2025 (Volume)
Figure Global Glucagon Like Peptide-1 (GLP-1) Agonists Market Size and CAGR 2013-2017 (Million USD)
Figure Global Glucagon Like Peptide-1 (GLP-1) Agonists Market Size and CAGR 2013-2017 (Volume)
Figure Global Glucagon Like Peptide-1 (GLP-1) Agonists Market Forecast and CAGR 2019-2025 (Million USD)
Figure Global Glucagon Like Peptide-1 (GLP-1) Agonists Market Forecast and CAGR 2019-2025 (Volume)
Figure China Glucagon Like Peptide-1 (GLP-1) Agonists Market Size and CAGR 2013-2017 (Million USD)
Figure China Glucagon Like Peptide-1 (GLP-1) Agonists Market Size and CAGR 2013-2017 (Volume)
Figure China Glucagon Like Peptide-1 (GLP-1) Agonists Market Forecast and CAGR 2019-2025 (Million USD)
Figure China Glucagon Like Peptide-1 (GLP-1) Agonists Market Forecast and CAGR 2019-2025 (Volume)
Figure Global Market Sales Revenue Share by Company in 2017
Figure Global Market Sales Volume Share by Company in 2017
Figure China Market Sales Revenue Share by Company in 2017
Figure China Market Sales Volume Share by Company in 2017
Figure Global Market Sales Revenue Share by Type in 2017
Figure Global Market Sales Volume Share by Type in 2017
Figure China Market Sales Revenue Share by Type in 2017
Figure China Market Sales Volume Share by Type in 2017
Figure Global Market Sales Revenue Share by Application in 2017
Figure Global Market Sales Volume Share by Application in 2017
Figure China Market Sales Revenue Share by Application in 2017
Figure China Market Sales Volume Share by Application in 2017
Figure Industry Chain Overview
Figure Glucagon Like Peptide-1 (GLP-1) Agonists SWOT List
Figure Glucagon Like Peptide-1 (GLP-1) Agonists Porter's Five Forces
